« Effectiveness and safety of the monoclonal antibody drug lecanemab (Leqembi) in reducing beta-amyloid plaques in alzheimer’s dementia: a literature review ». Journal of Health Management and Pharmacy Exploration, vol. 3, nᵒ 1, février 2025, https://doi.org/10.52465/johmpe.v3i1.547.